Literature DB >> 10885959

High-grade dysplasia in Barrett's esophagus: surveillance or operation?

C A Pellegrini1, D Pohl.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10885959     DOI： 10.1016/s1091-255x(00)80048-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  24 in total

1.  The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.

Authors:  M J Edwards; D R Gable; A B Lentsch; J D Richardson
Journal:  Ann Surg       Date:  1996-05       Impact factor: 12.969

2.  The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract. Guidelines for clinical application.

Authors: 
Journal:  Gastrointest Endosc       Date:  1988 May-Jun       Impact factor: 9.427

3.  Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia.

Authors:  G W Falk; M F Catalano; M V Sivak; T W Rice; J Van Dam
Journal:  Gastrointest Endosc       Date:  1994 Mar-Apr       Impact factor: 9.427

4.  Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy?

Authors:  M Pera; V F Trastek; H A Carpenter; M S Allen; C Deschamps; P C Pairolero
Journal:  Ann Thorac Surg       Date:  1992-08       Impact factor: 4.330

5.  Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.

Authors:  A J Cameron; H A Carpenter
Journal:  Am J Gastroenterol       Date:  1997-04       Impact factor: 10.864

6.  Barrett's esophagus, markers to distinguish risk groups.

Authors:  I Ferrando; J Ferrando; G Reig; P Navarro; A Llombart; M Mínguez; F Mora; A Benages
Journal:  Rev Esp Enferm Dig       Date:  1998-06       Impact factor: 2.086

7.  Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients.

Authors:  R G Lee
Journal:  Am J Surg Pathol       Date:  1985-12       Impact factor: 6.394

8.  Barrett's esophagus. Comparison of benign and malignant cases.

Authors:  D B Skinner; B C Walther; R H Riddell; H Schmidt; C Iascone; T R DeMeester
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

9.  High-grade dysplasia in the columnar-lined esophagus.

Authors:  N K Altorki; M Sunagawa; A G Little; D B Skinner
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

10.  Endoscopic surveillance of Barrett's esophagus. Does it help?

Authors:  J M Streitz; C W Andrews; F H Ellis
Journal:  J Thorac Cardiovasc Surg       Date:  1993-03       Impact factor: 5.209
View more
  19 in total

1.  Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.

Authors:  H Barr
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?

Authors:  M S Dar; J R Goldblum; T W Rice; G W Falk
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

Review 3.  Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?

Authors:  Vani J A Konda; Mark K Ferguson
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

4.  Endoscopic resection techniques and ablative therapies for Barrett's neoplasia.

Authors:  Jacobo Ortiz-Fernández-Sordo; Adolfo Parra-Blanco; Alejandro García-Varona; María Rodríguez-Peláez; Erika Madrigal-Hoyos; Irving Waxman; Luis Rodrigo
Journal:  World J Gastrointest Endosc       Date:  2011-09-16

5.  Minimally invasive esophagectomy for Barrett's with high-grade dysplasia and early adenocarcinoma of the esophagus.

Authors:  Arjun Pennathur; Omar Awais; James D Luketich
Journal:  J Gastrointest Surg       Date:  2010-04-01       Impact factor: 3.452

6.  Low risk of prevalent submucosal invasive cancer among patients undergoing esophagectomy for treatment of Barrett's esophagus with high grade dysplasia.

Authors:  Vani Ja Konda; Irving Waxman
Journal:  J Gastrointest Oncol       Date:  2011-03

Review 7.  Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma.

Authors:  Jacquelyn S Carr; Syed F Zafar; Nabil Saba; Fadlo R Khuri; Bassel F El-Rayes
Journal:  J Gastrointest Cancer       Date:  2013-06

8.  Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus.

Authors:  Lily C Chang; Brant K Oelschlager; Elina Quiroga; Juan D Parra; Michael Mulligan; Doug E Wood; Carlos A Pellegrini
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

9.  Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.

Authors:  Aaron J Small; James L Araujo; Cadman L Leggett; Aaron H Mendelson; Anant Agarwalla; Julian A Abrams; Charles J Lightdale; Timothy C Wang; Prasad G Iyer; Kenneth K Wang; Anil K Rustgi; Gregory G Ginsberg; Kimberly A Forde; Phyllis A Gimotty; James D Lewis; Gary W Falk; Meenakshi Bewtra
Journal:  Gastroenterology       Date:  2015-04-24       Impact factor: 22.682

Review 10.  Mucosal ablation of Barrett esophagus.

Authors:  Irving Waxman; Vani J A Konda
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06-02       Impact factor: 46.802
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.